ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Discontinuing Surveillance of Low‐Risk Branch‐Duct Intraductal Papillary Mucinous Neoplasms in Routine Practice: An External Application of the “Trivial” Criteria and the Resources it Would Release in Fourteen Health Systems

Study limitation reported by the research below: “The cohort contributed only 298 person-years after applying the discontinuation rule, leaving the upper 95% credible bound for missed high-grade lesions at 0.84 per 100 person-years — the study is compatible with safety but cannot establish it.”

Papers